Continuum Advisory, LLC T2 Biosystems, Inc. Transaction History

Continuum Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Dec 13, 2023	SELL	$0.46 - $0.94 $690 - $1,410	-1,500 Reduced 2.91%	50,000 $26,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $690 - $1,410	-1,500 Reduced 2.91%	50,000 $26,000
Q2 2021 Dec 13, 2023	BUY	$1.04 - $1.69 $53,560 - $87,035	51,500 New	51,500 $61,000
Q2 2021 Aug 17, 2021	BUY	$1.04 - $1.69 $858 - $1,394	825 Added 1.63%	51,500 $61,000
Q1 2021 May 14, 2021	BUY	$1.32 - $3.79 $891 - $2,558	675 Added 1.35%	50,675 $66,000
Q2 2020 May 18, 2021	BUY	$0.48 - $1.67 $4,800 - $16,700	10,000 Added 25.0%	50,000 $76,000
Q1 2020 May 18, 2021	BUY	$0.28 - $1.23 $8,400 - $36,900	30,000 Added 300.0%	40,000 $24,000
Q1 2019 May 18, 2021	BUY	$2.56 - $4.48 $25,600 - $44,800	10,000 New	10,000 $26,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Continuum Advisory, LLC with notifications on news.